Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction

Steven J. Keteyian, Debra Isaac, Udho Thadani, Brad A. Roy, Daniel R. Bensimhon, Robert McKelvie, Stuart D. Russell, Anne S. Hellkamp, William E. Kraus

Research output: Contribution to journalArticle

Abstract

Background: To assess the safety of symptom-limited exercise testing in patients with New York Heart Association class II-IV heart failure symptoms due to left ventricular systolic dysfunction, we investigated the frequency of all-cause fatal and nonfatal major cardiovascular (CV) events among subjects enrolled in a prospective clinical trial (HF-ACTION). We hypothesized that exercise testing would be safe, as defined by a rate for all-cause death of

Original languageEnglish (US)
JournalAmerican Heart Journal
Volume158
Issue number4 SUPPL.
DOIs
StatePublished - Oct 2009

Fingerprint

Left Ventricular Dysfunction
Heart Failure
Exercise
Safety
Cause of Death
Clinical Trials

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. / Keteyian, Steven J.; Isaac, Debra; Thadani, Udho; Roy, Brad A.; Bensimhon, Daniel R.; McKelvie, Robert; Russell, Stuart D.; Hellkamp, Anne S.; Kraus, William E.

In: American Heart Journal, Vol. 158, No. 4 SUPPL., 10.2009.

Research output: Contribution to journalArticle

Keteyian, SJ, Isaac, D, Thadani, U, Roy, BA, Bensimhon, DR, McKelvie, R, Russell, SD, Hellkamp, AS & Kraus, WE 2009, 'Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction', American Heart Journal, vol. 158, no. 4 SUPPL.. https://doi.org/10.1016/j.ahj.2009.07.014
Keteyian, Steven J. ; Isaac, Debra ; Thadani, Udho ; Roy, Brad A. ; Bensimhon, Daniel R. ; McKelvie, Robert ; Russell, Stuart D. ; Hellkamp, Anne S. ; Kraus, William E. / Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. In: American Heart Journal. 2009 ; Vol. 158, No. 4 SUPPL.
@article{15113d00588341969547050641459a3a,
title = "Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction",
abstract = "Background: To assess the safety of symptom-limited exercise testing in patients with New York Heart Association class II-IV heart failure symptoms due to left ventricular systolic dysfunction, we investigated the frequency of all-cause fatal and nonfatal major cardiovascular (CV) events among subjects enrolled in a prospective clinical trial (HF-ACTION). We hypothesized that exercise testing would be safe, as defined by a rate for all-cause death of",
author = "Keteyian, {Steven J.} and Debra Isaac and Udho Thadani and Roy, {Brad A.} and Bensimhon, {Daniel R.} and Robert McKelvie and Russell, {Stuart D.} and Hellkamp, {Anne S.} and Kraus, {William E.}",
year = "2009",
month = "10",
doi = "10.1016/j.ahj.2009.07.014",
language = "English (US)",
volume = "158",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction

AU - Keteyian, Steven J.

AU - Isaac, Debra

AU - Thadani, Udho

AU - Roy, Brad A.

AU - Bensimhon, Daniel R.

AU - McKelvie, Robert

AU - Russell, Stuart D.

AU - Hellkamp, Anne S.

AU - Kraus, William E.

PY - 2009/10

Y1 - 2009/10

N2 - Background: To assess the safety of symptom-limited exercise testing in patients with New York Heart Association class II-IV heart failure symptoms due to left ventricular systolic dysfunction, we investigated the frequency of all-cause fatal and nonfatal major cardiovascular (CV) events among subjects enrolled in a prospective clinical trial (HF-ACTION). We hypothesized that exercise testing would be safe, as defined by a rate for all-cause death of

AB - Background: To assess the safety of symptom-limited exercise testing in patients with New York Heart Association class II-IV heart failure symptoms due to left ventricular systolic dysfunction, we investigated the frequency of all-cause fatal and nonfatal major cardiovascular (CV) events among subjects enrolled in a prospective clinical trial (HF-ACTION). We hypothesized that exercise testing would be safe, as defined by a rate for all-cause death of

UR - http://www.scopus.com/inward/record.url?scp=70349431338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349431338&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2009.07.014

DO - 10.1016/j.ahj.2009.07.014

M3 - Article

VL - 158

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 4 SUPPL.

ER -